Controversies in dyslipidaemia management

MeSH terms

• Adolescent
• Adult
• Aged
• Biomarkers / blood
• Cardiovascular Diseases / economics
• Cardiovascular Diseases / etiology
• Cardiovascular Diseases / prevention & control*
• Cost-Benefit Analysis
• Drug Costs
• Dyslipidemias / blood
• Dyslipidemias / complications
• Dyslipidemias / economics
• Dyslipidemias / therapy*
• Evidence-Based Medicine
• Female
• Health Care Costs
• Humans
• Hypolipidemic Agents / adverse effects
• Hypolipidemic Agents / economics
• Hypolipidemic Agents / therapeutic use*
• Male
• Middle Aged
• Practice Guidelines as Topic
• Risk Reduction Behavior*
• Treatment Outcome
• Young Adult